Welcome to BrainsCAN

In September 2016, BrainsCAN received a 7-year, $66 million investment from the Government of Canada (through the Canada First Research Excellence Fund) to enable Western researchers, along with national and international academic and commercial partners, to develop and deliver evidence-based assessments and interventions for the diagnosis and treatment of disorders of the brain.

This knowledge will radically transform our understanding of brain disorders and lead to evidence-based interventions in the classroom, in the operating room and in the clinic. BrainsCAN will accelerate Canada’s ability to deliver effective solutions to the challenge of maintaining optimal brain function across the lifespan.

BrainsCAN's goal is to reduce the burden of brain disorders, which affect nearly 3.6 million Canadians, diminishing quality of life and creating an enormous burden on society and on our health-care system. Neurological and psychiatric disorders together account for $22.7 billion per year in health-care costs in Canada.